Federated Hermes’s Cerevel Therapeutics Holdings CERE Stock Holding History
Bought
Maintained
Sold
Other funds holding CERE
Federated Hermes's CERE Position: Q3 2023 in Review
Federated Hermes sold out of Cerevel Therapeutics Holdings (CERE) in Q3 2023, closing a stake of 1,214,972 shares — an estimated $38.6M sold.
Federated Hermes first reported a position in CERE in Q4 2020 and held it in 11 quarters. The position peaked at $109M in Q1 2022. 119 funds tracked by Wall St. Rank hold CERE as of Q3 2023.
- Federated Hermes reported no remaining Cerevel Therapeutics Holdings position as of Q3 2023 after selling out during the quarter.
- Federated Hermes sold 1,214,972 Cerevel Therapeutics Holdings shares in Q3 2023, an estimated $38.6M.
- Federated Hermes first reported a position in Cerevel Therapeutics Holdings in Q4 2020 and held it in 11 quarters.
- Federated Hermes's Cerevel Therapeutics Holdings position peaked at $109M in Q1 2022.
- 119 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings as of Q3 2023.
Based on Federated Hermes's 13F filing for Q3 2023, filed 13 Nov 2023.